ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

AGIO Agios Pharmaceuticals Inc

32.60
0.10 (0.31%)
01 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Agios Pharmaceuticals Inc AGIO NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.10 0.31% 32.60 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
32.30 32.30 34.58 33.66 32.50
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
18/4/202406:00GLOBEAgios to Webcast Conference Call of First Quarter 2024..
09/4/202406:00GLOBEAgios Publishes 2024 Environmental, Social and Governance..
07/3/202417:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202406:00GLOBEAgios to Present at the Leerink Partners Global Biopharma..
01/3/202415:27EDGAR2Form 144 - Report of proposed sale of securities
01/3/202415:26EDGAR2Form 144 - Report of proposed sale of securities
01/3/202415:25EDGAR2Form 144 - Report of proposed sale of securities
01/3/202415:22EDGAR2Form 144 - Report of proposed sale of securities
29/2/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202415:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202420:21EDGAR2Form 144 - Report of proposed sale of securities
22/2/202416:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202406:00GLOBEAgios to Present at the TD Cowen 44th Annual Health Care..
15/2/202409:33EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15/2/202406:03EDGAR2Form 8-K - Current report
15/2/202406:00GLOBEAgios Reports Fourth Quarter and Full Year 2023 Financial..
14/2/202416:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202416:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202416:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202413:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202413:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
02/2/202406:00GLOBEAgios to Webcast Conference Call of Fourth Quarter and Year..
24/1/202415:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202415:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202415:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202415:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202415:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202415:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202415:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202415:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202406:58EDGAR2Form 8-K - Current report
08/1/202406:00GLOBEAgios Announces Key Anticipated 2024 Milestones Across Rare..
05/1/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202405:30GLOBEAgios Announces Phase 3 ENERGIZE Study of Mitapivat Met..
02/1/202406:00GLOBEAgios to Present at the 42nd Annual J.P. Morgan Healthcare..
09/12/202318:00GLOBEAgios Presents Positive Results from Phase 2 Portion of the..
20/11/202306:00GLOBEAgios Announces Clinical Proof-of-Concept in Phase 2a Trial..
02/11/202308:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202308:05GLOBEAgios Pharmaceuticals to Present Broad Set of Clinical and..
02/11/202306:02EDGAR2Form 8-K - Current report
02/11/202306:00GLOBEAgios Reports Business Highlights and Third Quarter 2023..
28/9/202315:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202306:00GLOBEAgios to Present at the Morgan Stanley Global Healthcare..
21/8/202315:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202315:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

Delayed Upgrade Clock